{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:19:24Z","timestamp":1790266764638,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015027","name":"Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["9905283342"],"award-info":[{"award-number":["9905283342"]}],"id":[{"id":"10.13039\/501100015027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.imbio.2021.152113","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T11:39:46Z","timestamp":1625485186000},"page":"152113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Reduced frequency and functional potency of CD49d\u2212 T regulatory cells in patients with newly diagnosed type 2 diabetes mellitus"],"prefix":"10.1016","volume":"226","author":[{"given":"Shiva","family":"Borzouei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Mohamadtaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6146-6013","authenticated-orcid":false,"given":"Alireza","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8940-3847","authenticated-orcid":false,"given":"Mahdi","family":"Behzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2021.152113_b0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fchem.2019.00489","article-title":"Novel ligands targeting alpha4beta1 integrin: therapeutic applications and perspectives","volume":"7","author":"Baiula","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.imbio.2021.152113_b0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/jir.2018.0144","article-title":"Anti-inflammatory effect of combined sitagliptin and vitamin d3 on cytokines profile in patients with type 2 diabetes mellitus","volume":"39","author":"Borzouei","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.imbio.2021.152113_b0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/immu.200390024","article-title":"Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis","volume":"33","author":"Cao","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2021.152113_b0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2021.152113_b0025","doi-asserted-by":"crossref","first-page":"7834","DOI":"10.1038\/srep07834","article-title":"Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4","volume":"5","author":"Glatigny","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imbio.2021.152113_b0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13075-020-02183-2","article-title":"A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus","volume":"22","author":"Hanaoka","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imbio.2021.152113_b0035","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1167\/iovs.08-2013","article-title":"Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy","volume":"50","author":"Iliaki","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.imbio.2021.152113_b0040","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.immuni.2008.03.018","article-title":"Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery","volume":"28","author":"Ito","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2021.152113_b0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2021.152113_b0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2008-04-150524","article-title":"CD49d provides access to \u201cuntouched\u201d human Foxp3+ Treg free of contaminating effector cells","volume":"113","author":"Kleinewietfeld","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2021.152113_b0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000363004","article-title":"CD49d Treg cells with high suppressive capacity are remarkably less efficient on activated CD45RA- than on naive CD45RA+ Teff cells","volume":"34","author":"Kraczyk","year":"2014","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.imbio.2021.152113_b0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12865-015-0116-x","article-title":"CD4(+)CD25(High) Treg cells in HIV\/HTLV co-infected patients with neuropathy: high expression of Alpha4 integrin and lower expression of Foxp3 transcription factor","volume":"16","author":"Matavele Chissumba","year":"2015","journal-title":"BMC Immunol."},{"key":"10.1016\/j.imbio.2021.152113_b0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1172\/JCI118406","article-title":"Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice","volume":"97","author":"Onrust","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2021.152113_b0070","first-page":"3989","article-title":"Comparative analysis of gene expression profiles in children with type 1 diabetes mellitus","volume":"19","author":"Qian","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.imbio.2021.152113_b0075","doi-asserted-by":"crossref","first-page":"3694957","DOI":"10.1155\/2016\/3694957","article-title":"Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"2016","author":"Qiao","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.imbio.2021.152113_b0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.imbio.2021.152113_b0085","doi-asserted-by":"crossref","first-page":"2974605","DOI":"10.1155\/2016\/2974605","article-title":"Reduced numbers and impaired function of regulatory T cells in peripheral blood of ischemic stroke patients","volume":"2016","author":"Ruhnau","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.imbio.2021.152113_b0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2021.152113_b0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cei.13289","article-title":"Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes","volume":"197","author":"Singh","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2021.152113_b0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/08923973.2019.1593447","article-title":"Effects of sitagliptin and vitamin D3 on T helper cell transcription factors and cytokine production in clinical subgroups of type 2 diabetes mellitus: highlights upregulation of FOXP3 and IL-37","volume":"41","author":"Telikani","year":"2019","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.imbio.2021.152113_b0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/-) T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imbio.2021.152113_b0110","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.exphem.2011.08.010","article-title":"Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity","volume":"39","author":"Ukena","year":"2011","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.imbio.2021.152113_b0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","article-title":"Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level","volume":"123","author":"Venken","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.imbio.2021.152113_b0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clim.2018.09.005","article-title":"Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients","volume":"197","author":"Wang","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imbio.2021.152113_b0125","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/jgh.12202","article-title":"Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients","volume":"28","author":"Wu","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.imbio.2021.152113_b0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1083\/jcb.201110023","article-title":"Structural specializations of alpha(4)beta(7), an integrin that mediates rolling adhesion","volume":"196","author":"Yu","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.imbio.2021.152113_b0135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","article-title":"The alteration of Th1\/Th2\/Th17\/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy","volume":"75","author":"Zhang","year":"2014","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.imbio.2021.152113_b0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298521000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298521000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:48:24Z","timestamp":1759250904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298521000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0171298521000619"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2021.152113","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced frequency and functional potency of CD49d\u2212 T regulatory cells in patients with newly diagnosed type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2021.152113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152113"}}